A nasal HPV vaccine has been shown to shrink cervical cancer tumors in mice, researchers reported in Science Translational Medicine last month. The vaccine targets HPV16 E7, a protein made by the human papillomavirus (HPV) that targets a tumor suppressor and causes uncontrolled cell growth. Unlike most vaccines, which are preventative, this medicine could be…